Biotechnology company Biocon has launched the first anti-CD6 monoclonal antibody, alzumab (Itolizumab), to treat patients with chronic plaque psoriasis in India. Indicated for the treatment of moderate-to-severe psoriasis, Alzumab is ...
LEO Pharma Taclonex (calcipotriene and betamethasone dipropionate) topical suspension, 0.005%/0.064% has won FDA approval for body plaque psoriasis. With the approval, the only once-daily, steroid-containing topical treatment is now ...
Tags: body plaque psoriasis, Medicine
AbGenomics International, a biopharmaceutical company, has obtained FDA agreement on Its Phase 2 clinical trial plans of the novel autoimmune therapeutic candidate, AbGn-168H. The current Phase 2 AbGn-168H trial will be a multicenter, ...
Tags: FDA approval, psoriatic, clinical trial, pharmaceutical product